Perstorp Holding AB Overview
Perstorp is a 145-year-old Swedish specialty chemicals producer built on two proprietary technology platforms — polyols (pentaerythritol/Penta, trimethylolpropane/TMP, neopentyl glycol/Neo and their dimers) and oxo chemistry (aldehydes, C4–C10 alcohols, carboxylic acids and plasticizers) — feeding downstream niches in coatings and resins, engineered fluids (synthetic lubricant esters, dielectric and data-centre cooling fluids), plastic additives and animal nutrition (feed acidifiers and preservatives). It claims global number-one positions in TMP and Penta. Since October 2022 Perstorp has been the anchor of PETRONAS Chemicals Group's Specialty Chemicals (SC) division alongside BRB International, giving a Europe-centric, high-sustainability-profile asset base (nine production units in Europe, North America and Asia) an Asian parent with feedstock depth and a balance sheet. The investment case has been tested: the SC division swung to a RM707m net loss in FY2025 after a RM439m impairment of Perstorp's North American assets, followed by an 8% workforce reduction and a marked recovery in H1 2026.
What the company does. Perstorp manufactures and sells intermediate and specialty chemicals produced from two integrated chemistries:
-
Polyols platform — Penta, Di-Penta, TMP, Di-TMP, Neo, DMPA and related specialty polyols, used as building blocks for alkyd and polyester resins, powder coatings, UV-curing systems, polyurethane dispersions, synthetic lubricant esters, and as intermediates for antioxidants and flame-retardants. By-product calcium formate and sodium formate are sold into construction, leather and feed markets.
-
Oxo platform (Stenungsund, Sweden) — Propylene-based hydroformylation producing butyraldehyde, valeraldehyde, 2-ethylhexanol (2-EH), 2-propylheptanol (2-PH), C8–C10 oxo alcohols, carboxylic acids (e.g., 2-ethylhexanoic acid, valeric acid, propionic acid) and plasticizers (Pevalen™ polyol-ester plasticizer; Emoltene™ 100 non-phthalate plasticizer). Carboxylic acids feed in-house formulated preservatives (Profina™ for food, ProSid™ for feed).
Business model. Perstorp is a product company with no material service, subscription or licensing revenue disclosed. Revenue derives from tonnage sales under a mix of contract and spot terms, with an explicit "value-based pricing / Pricing Excellence" programme referenced by management in the Q1 2022 report. A growing share of sales is "Pro-Environment" (renewable- or recycled-attributed, ISCC PLUS mass-balance-certified) grades sold at a premium — Pro-Environment sales rose 30% in 2024 vs 2023 (Sustainability Report 2024).
Value-chain position. Mid-stream: Perstorp buys commodity feedstocks (methanol, formaldehyde — partly self-produced — acetaldehyde, propylene, synthesis gas, n-butyraldehyde) and converts them to differentiated intermediates sold to formulators (paint/resin makers, lubricant blenders, PVC compounders, feed premixers). It is partly backward-integrated (Oxo in Stenungsund; formaldehyde in Perstorp) and partly forward-integrated (formulated feed additives; plasticizers; esters).
Customer types. More than 2,600 customers (PCG deal announcement, May 2022) — principally multinational and regional coatings and resin producers, lubricant and fluid formulators, PVC compounders, adhesives/sealants makers, personal-care ingredient formulators, feed premix and compound feed producers, and food processors.
End-markets. Paints and coatings, construction, automotive, plastic additives (PVC), synthetic lubricants (aviation, refrigeration, industrial), data-centre and transformer dielectric fluids, personal care, food and animal feed/nutrition (PCG and Perstorp, 2022 deal communications).
Company's own description (paraphrased from latest available communications). Perstorp describes itself as a global specialty chemicals innovator and sustainable solutions provider, and, since January 2025, as part of PCG SC whose stated ambition is to become a globally leading specialty chemicals company by leading in four focus segments — Coating Solutions, Engineered Fluids Solutions, Personal Care Solutions and Advanced Polymer Solutions — while aggressively expanding the intermediates business (Perstorp press release, January 2025).
Independent characterisation. Perstorp is better described as a "specialty-tilted intermediates" producer than a pure specialty company. Its core polyol and oxo molecules are globally traded with Chinese and Middle-Eastern competition, so earnings are strongly cyclical (EBITDA margin swung from 12.3% in FY2020 to 18.6% in FY2021, and the PCG SC division's EBITDA margin was only ~2.8–5.1% in FY2023–FY2025). Its genuine differentiation lies in (a) scale leadership in Penta/TMP, (b) integrated oxo-to-plasticizer chemistry in Europe, (c) a first-mover position in mass-balance renewable grades, and (d) downstream formulated niches (feed acidifiers, dielectric esters). The strategic question since 2022 is whether PCG's ownership can shift the mix toward the formulated end fast enough to offset structurally higher European energy and compliance costs.
Strategy
Stated strategy themes (paraphrased).
-
Become a globally leading specialty chemicals company within PCG SC, leading in four focus segments (Coating, Engineered Fluids, Personal Care, Advanced Polymer Solutions) while expanding intermediates aggressively (Jan 2025).
-
Sustainable solutions provider / Finite Material Neutral — long-term ambition to eliminate dependence on finite raw materials, energy and catalysts; 2030 science-based targets (Scope 1 & 2 −46.2% vs 2019).
-
Pricing Excellence / value-based pricing (2021–22 strategy).
-
Asia growth via Sayakha, Zibo and PCG's channels.
-
Shift to higher-value markets — PCG CEO Mazuin Ismail's FY2025 statement highlighting synthetic esters for transformer fluids.
Initiatives in the last 24 months (Oct 2024–Oct 2026).
Medium-term financial targets/guidance. None disclosed for Perstorp. PCG states specialty chemicals is a medium-to-long-term value creation business requiring "nurturing", with returns expected to improve progressively as markets normalise (Apr 2026); no IRR or break-even date given despite shareholder questions. At acquisition, PCG targeted 30% of revenue from non-traditional (specialty) businesses by 2030.
Products & Services
Pricing models are not publicly disclosed for any product line; Perstorp sells on negotiated contract/spot terms. Launch years given where disclosed.
Coating Solutions / Resins & Coatings
| Product / brand | Description & capabilities | Target customer | Year / latest |
|---|---|---|---|
| Penta (pentaerythritol), Penta Mono | Tetra-functional polyol; building block for alkyd resins, rosin esters, synthetic lubricants, antioxidants, intumescent coatings. Produced in Perstorp (SE), Bruchhausen (DE), Toledo (US), Sayakha (IN) | Resin makers, lubricant ester makers | Sayakha capacity 40 kt/yr from Feb 2024 |
| Voxtar™ (incl. Voxtar M40) | Renewable / ISCC PLUS mass-balance Penta grades with reduced carbon footprint | Coatings majors with Scope 3 targets | Voxtar M40 produced at Sayakha from 2024 |
| Di-Penta | Hexa-functional polyol for UV-curing acrylates and high-performance esters | Radiation-curing and lubricant formulators | Sayakha and other sites |
| TMP (trimethylolpropane), Di-TMP | Tri-/tetra-functional polyols for polyester and alkyd resins, polyurethanes, UV monomers, lubricants. Perstorp claims global #1 in TMP | Resin, PU and UV-cure producers | Zibo TMP since 2008 |
| Evyron™ (renewable TMP) | Mass-balance renewable TMP (brand per Perstorp catalog; not re-verified in this research) | Coatings | — |
| Neo (neopentyl glycol) / Neeture™ | Diol for saturated polyesters, powder coatings, gel coats; renewable variant Neeture (brand not re-verified) | Powder coating and polyester resin makers | Zibo Neo plant |
| DMPA (dimethylolpropionic acid) / Bis-MPA | Hydrophilic diol enabling waterborne polyurethane dispersions and dendritic polymers; acquired from GEO Specialty Chemicals end-2021 | Waterborne PU and coating formulators | Acquired 2021 |
| Neptem™ emulsifier range | Emulsifiers enabling high-performance, low-VOC waterborne alkyd coatings | Decorative and industrial paint makers | Launched 12 Mar 2025 |
| Boltorn™ dendritic polymers / Ymer™ | Hyperbranched polymers and specialty non-ionic diols for coatings (legacy brands; current commercial status not re-verified) | Specialty coatings | Legacy |
Engineered Fluids Solutions
| Product / brand | Description & capabilities | Target customer | Year |
|---|---|---|---|
| Synthetic polyol esters (saturated) | New portfolio of saturated synthetic polyol esters for high-performance lubricants | Synthetic lubricant blenders (industrial, refrigeration, aviation) | Launched 2025 |
| Synmerse™ DC | Biodegradable, high-performance synthetic dielectric coolant for immersion cooling of data centres; showcased at Data Center World Asia, Singapore | Hyperscale/colocation data-centre operators, immersion-cooling OEMs | Launched Oct 2024 |
| Synthetic ester dielectric fluids (Amsterdam) | Transformer-fluid esters from the former OQ Chemicals Nederland plant; first customer delivery July 2025 | Transformer OEMs and utilities | Production from 2025 |
| Polyol-ester base stocks (Penta/TMP/Neo-based) | Ester building blocks for lubricants and refrigeration oils | Lubricant formulators | Long-standing |
| Liquid-cooling collaboration with Intel | Joint work on advanced liquid-cooling solutions | Data-centre ecosystem | 2024 (per F&L Asia) |
Advanced Polymer Solutions / Plastic additives & Oxo
| Product / brand | Description & capabilities | Target customer | Year |
|---|---|---|---|
| Pevalen™ | Non-phthalate polyol-ester PVC plasticizer | Flexible PVC compounders (flooring, wall-covering, cables) | Stenungsund-integrated |
| Pevalen™ Pro | Renewable/ISCC grade of Pevalen (brand variant not re-verified) | Same | — |
| Emoltene™ 100 | Non-phthalate general-purpose plasticizer with 100% renewable carbon content (mass balance) | PVC compounders seeking low-carbon additives | Feb 2024 |
| 2-Propylheptanol (2-PH), Valeraldehyde | Key oxo intermediates for plasticizers, lubricants, adhesives, surfactants; Oxo capacity raised to 150 kt/yr with new plant | Plasticizer and surfactant producers | Oxo plant 2017 |
| 2-Ethylhexanol (2-EH), butyraldehyde | Oxo alcohol/aldehyde intermediates | Plasticizers, acrylates, coatings | Long-standing |
| C8–C10 oxo alcohols | Portfolio expanded in Asia in cooperation with PETRONAS | Asian plasticizer/surfactant users | Sep 2024 |
| Carboxylic acids (2-EHA, valeric, propionic, others) | Used in-house and sold for lubricant esters, metal soaps, preservatives; ~70 kt/yr extra capacity planned for 2024 | Ester, catalyst-dryer, feed/food producers | Expansion announced Apr 2022 |
Animal Nutrition & Food (Perstorp Animal Nutrition)
| Product / brand | Description & capabilities | Target customer | Year |
|---|---|---|---|
| ProSid™ (incl. ProSid MI 208) | Feed preservatives/acidifiers based on in-house carboxylic acids | Feed mills, premixers | Long-standing |
| ProPhorce™ | Gut-health feed additives (e.g., butyrate/organic-acid based; composition per Perstorp catalog, not re-verified) | Poultry/swine integrators | Long-standing |
| Profina™ CP (calcium propionate) | Food preservative for bakery; capacity located in Castellanza, Italy, with expansion under evaluation (2022) | Bakery/food processors | Expansion plan 2022 |
| Waspik formulated additives | Production of feed additive formulations; Scope 1 & 2 emissions reported at zero for 2024 | Feed industry | Zero-emission status Feb 2025 |
Formates & other
| Product | Description | Target | Year |
|---|---|---|---|
| Calcium formate | By-product of Penta; used as concrete set-accelerator, in leather tanning and feed; 26 kt/yr at Sayakha | Construction chemicals, feed, leather | 2024 (Sayakha) |
| Sodium formate | Penta co-product; de-icing, leather, drilling | Industrial | Long-standing |
| Formaldehyde (captive) | Produced on site in Perstorp for polyol production | Internal | — |
Personal Care Solutions. PCG SC lists Personal Care as a focus segment; on the Perstorp side this draws on polyols and esters for cosmetic emollients and ingredients. Specific Perstorp personal-care brands are not disclosed in the sources reviewed; much of this segment's content may sit within BRB (silicones). Flagged as n/d at Perstorp level.
Divested lines (not current portfolio). Capa™ caprolactones (divested 2019), BioProducts/RME biodiesel (2018), Formox catalysts (2014), Pergo laminate flooring (historical, spun out decades ago — secondary source).
PCG SC innovation count. PCG reports 30 new products launched under the SC portfolio since the acquisition (MSWG reply, Apr 2026).
Financial Narrative
Disclosure constraint. Perstorp stopped publishing group financial reports after the Q2 2022 interim report (closing of PCG acquisition, October 2022). Perstorp Holding AB files statutory annual reports with Bolagsverket, but group-level figures for FY2022–FY2025 were not accessible in this research. Accordingly, the analysis uses two series: (A) Perstorp group as reported FY2017–FY2021 (+ LTM Q2 2022) in SEK, and (B) PCG Specialty Chemicals division FY2023–FY2025 in RM. The two are not comparable (B includes BRB and is in a different currency and accounting perimeter).
6A. Perstorp Group — income statement
Sources: Perstorp AR 2018 press release (FY2018, FY2017 EBITDA comparative); AR 2019 (FY2019 continuing operations; FY2019 "−6%" growth is vs restated continuing FY2018 ≈ SEK 12.4bn, hence the FY2018 figure is on a pre-divestment basis — discontinuity); Q2 2021 report and AR 2021 (FY2020–FY2021). FY2021 net earnings from Q2 2022 interim report. Discrepancy: the Q2 2022 report shows FY2021 reported EBITDA (incl. NRI) of SEK 2,465m, vs EBITDA excl. NRI of SEK 2,513m in the AR 2021 — the difference is non-recurring items.
Gross profit, operating income (EBIT), pre-tax income, EPS and dividends per share for FY2017–FY2021: not publicly disclosed in sources accessed (Perstorp was privately held; EPS and DPS are not meaningful). For reference, FY2015 EBIT was SEK 971m (8.7% margin) and net loss SEK −660m (Q1 2016 interim report).
LTM to Q2 2022 (last Perstorp-published figures, SEK M): net sales 15,972; EBITDA (reported) 2,799; net earnings 948; financial net −991 (Q2 2022 interim report). H1 2022: net sales 8,573 (+40%), EBITDA margin excl. NRI 16.5%; Q2 2022 net loss −40 driven by −314 FX effect on net debt.
Euro-denominated reference (deal documents): FY2021 revenue EUR 1.33bn, EBITDA EUR 248m (18.6%) (PCG/MIDA, May 2022). Implied acquisition EV/EBITDA FY2021 ≈ 9.3x; EV/Sales ≈ 1.7x.
6B. Perstorp Group — balance sheet & liquidity: notes and sources
Sources: AR 2019; Q4 2020 report. Mid-2021 available funds: SEK 2,406m (Q2 2021). Total assets, equity, goodwill, working capital and debt maturity split: n/d in sources accessed. Historical context: net debt SEK 11,609m (FY2015) and 10,970m (FY2014) per AR 2015.
6C. Perstorp Group — cash flow
Quarterly free cash flow from Q4 2020 and Q4 2021 reports. Q1 2022 FCF SEK 291m; Q2 2021 FCF SEK 409m. Full-year operating cash flow, capex, dividends and buybacks: n/d. As a PE-owned then PCG-owned company, no public dividends or buybacks.
6D. Ratios
ROE, ROA, ROIC, current ratio, debt/equity, interest coverage, asset turnover and cash-conversion cycle: not publicly disclosed for FY2021–FY2025. Leverage of 5.5–5.6x (FY2018–FY2019) and a SEK −991m LTM financial net (to Q2 2022, incl. FX) illustrate the PE-era capital structure. Post-acquisition, Perstorp's debt is understood to be refinanced within the PCG group (shareholder funding), but terms are n/d.
6E. PCG Specialty Chemicals division (post-acquisition proxy, RM M)
Source: PCG IR 2023–2025 via MSWG reply (Apr 2026); ratios computed.
Commentary. Three inflections stand out. First, the 2021–H1 2022 super-cycle: post-COVID restocking and tight European supply let Perstorp push prices (+63% price effect in Q4 2021) faster than raw-material inflation, producing the highest EBITDA in its history (SEK 2,513m, 18.6%) — the earnings base PAI sold into at ~9x EBITDA. Second, the 2023–2025 normalisation and downturn: under PCG the combined SC division generated EBITDA margins of only 2.8–5.1% — a dramatic contrast with Perstorp's own 12–19% historical range even allowing for BRB, perimeter, IFRS and allocation differences. Drivers cited by PCG are weaker demand in construction and automotive, persistent pricing pressure from new Asian capacity, high European energy costs and widening regional price disparities. Revenue per tonne fell ~11% FY2023→FY2025, confirming price-led deflation. FY2025's RM707m loss includes the RM439m impairment on North American (Toledo) assets — PCG's first impairment on Perstorp. Third, a 2026 rebound: the West Asia conflict tightened global supply from February 2026; SC EBITDA reached RM198m in 1Q 2026 (boosted by emission-rights sales) and RM140m in 2Q 2026, and the Specialties segment returned to a RM63m profit after tax in 2Q 2026 vs a RM302m loss a year earlier. H1 2026 SC EBITDA of ~RM338m already exceeds full-year FY2025 (RM223m), although part is non-recurring.
Revenue CAGR. Perstorp FY2018–FY2021 is distorted by divestments; continuing operations FY2019–FY2021: (13,537/11,641)^(1/2) − 1 ≈ +7.8% p.a. PCG SC FY2023–FY2025: (5,693/6,385)^(1/2) − 1 ≈ −5.6% p.a. (RM terms, partly reflecting ringgit appreciation against USD/EUR in 2025).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
Net sales (SEK Mn) | — | 14,882 | 11,641 | 9,194 | 13,537 |
EBITDA excl. non-recurring items (SEK Mn) | 2,133 | 2,324 | 1,554 | 1,128 | 2,513 |
EBITDA margin excl. NRI (%) | 15.7 | 15.6 | 13.4 | 12.3 | 18.6 |
Net earnings (SEK Mn) | — | — | — | — | 979 |
Net sales YoY growth (%) | — | 9 | -6 | -21 | 47 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet and Financial Ratios (x)
| Metric | FY2018 | FY2019 | FY2020 |
|---|---|---|---|
Net debt incl. pension liability (SEK Mn) | 13,103 | 8,526 | — |
Net debt / EBITDA (x) | 5.6 | 5.5 | — |
Available funds — liquidity + unused facilities (SEK Mn) | 1,120 | 1,248 | 2,037 |
Cash Flow
| Metric | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
Q4 free cash flow (SEK Mn) | 549 | 364 | 388 |
Income Statement and Margin Analysis (%) (FY2023–FY2025)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Revenue (MYR Mn) | 6,385 | 6,542 | 5,693 |
EBITDA (MYR Mn) | 179 | 332 | 223 |
Net profit (MYR Mn) | -198 | 46 | -707 |
EBITDA margin (%) | 2.8 | 5.1 | 3.9 |
Net margin (%) | -3.1 | 0.7 | -12.4 |
Sales volume (kt) | 841 | 897 | 844 |
Revenue per tonne (ZAR Mn) | 7,592 | 7,293 | 6,745 |
Capital Markets
| Item | Status |
|---|---|
Share price performance (1/3/5-yr) | Not applicable — Perstorp unlisted since 2001 |
Valuation multiples | Not applicable. Transaction multiples (May 2022): EV/FY2021 EBITDA ≈ 9.3x; EV/FY2021 sales ≈ 1.7x |
Analyst consensus | None on Perstorp; covered indirectly via PCG (e.g., RHB "Sell", TP RM3.22, Aug 2025; Maybank "Sell", TP RM2.59; CIMB "Hold", TP RM3.45, Aug 2025) |
Dividend history / policy | No public dividends; upstream distributions to PCG n/d |
Credit ratings | PCG ratings: n/d in this research |
Debt maturity profile | n/d; post-2022 funding understood to be intra-group |
Capital Markets Data and Financial Ratios (x)
| Metric | FY2018 | FY2019 |
|---|---|---|
Net debt incl. pensions (SEK Mn) | 13,103 | 8,526 |
Leverage net debt/EBITDA (x) | 5.6 | 5.5 |
Analyst Conclusions
Management guidance. No Perstorp-specific guidance. PCG (Aug 2026) expects 2026 to remain challenging amid geopolitical uncertainty, trade-policy shifts and supply-demand imbalances, and is cautious on specialties given subdued construction and automotive markets, with modest consumer-goods growth. PCG reiterates that specialty returns should improve progressively as markets normalise.
Consensus. No Perstorp consensus exists. Broker coverage of PCG in 2025 cut earnings forecasts for FY2025–FY2027 and flagged risk of further Perstorp impairments.
Bull case
-
Cyclical leverage proven: Perstorp delivered 18.6% EBITDA margins in FY2021; the 2026 supply shock already lifted SC EBITDA to RM338m in H1 2026 (vs RM223m for all of FY2025).
-
Cost and asset reset: the 2025 impairment and ~8% headcount cut lower the depreciation and fixed-cost base, raising operating leverage into any recovery.
-
Growth niches with structural demand: dielectric esters (deliveries since Jul 2025), immersion cooling (Synmerse DC), non-phthalate plasticizers and low-VOC coatings, supported by Asia capacity (Sayakha) and PCG channels.
Bear case
-
Structural, not cyclical, margin erosion: three consecutive years of sub-6% SC EBITDA margin and falling revenue per tonne point to Asian overcapacity that the 2026 conflict only temporarily masks.
-
Quality of 2026 earnings: 1Q 2026 included emission-rights sale gains; 2Q 2026 profit was helped by favourable FX — underlying improvement may be smaller than headline.
-
Strategic drift: leadership churn, the stalled Project Air flagship and a parent portfolio review raise the risk of further impairments or partial disposals.
Key catalysts / monitorables (next 12 months)
-
PCG 3Q 2026 (Nov 2026) and FY2026 (Feb 2027) SC EBITDA, ex-one-offs.
-
Any further impairment testing outcome on Perstorp goodwill/PPE at FY2026.
-
Outcome of PCG's portfolio review; any asset sale or closure (Toledo, European units).
-
Perstorp Holding AB FY2025/FY2026 statutory group accounts (Bolagsverket) for standalone visibility.
-
Project Air FID or formal cancellation; status of EU grant.
-
Commercial traction of Amsterdam esters and Synmerse DC.
-
Durability of West Asia–driven price increases (May 2026 oxo/plasticizer hike).
-
Executive appointments following 2026 departures.
Analyst verdict. Perstorp is a high-quality, technology-rich chemical franchise caught in a low-quality industrial cycle. Its core assets — global leadership in Penta and TMP, an integrated European oxo chain, and an early, credible position in certified renewable grades — are genuine and hard to replicate. The 2021 record year showed what the business can earn when European supply is tight and pricing discipline holds. But the evidence since PETRONAS Chemicals paid an enterprise value of EUR 2.3bn in 2022 is sobering: the combined Specialty Chemicals division has delivered EBITDA margins of roughly 3–5%, a cumulative net loss of about RM860m over FY2023–FY2025, and PCG's first impairment of Perstorp assets. Management continuity has been weak, the flagship Project Air decarbonisation investment has stalled, and standalone financial disclosure has disappeared, making independent assessment difficult.
The 2026 rebound is real but must be read cautiously. A war-driven supply shock, emission-rights sales and currency effects explain much of the improvement; none is a durable competitive advantage. The structural question — whether a Europe-centred intermediates producer can earn its cost of capital against expanding Asian capacity — remains unanswered. The most constructive path is the one PCG is pursuing: shrinking the fixed-cost base, pushing volume growth through Asian assets, and redeploying Perstorp's ester and polyol know-how into faster-growing niches such as dielectric and data-centre fluids. Those niches are still small relative to the group.
On balance, Perstorp's intrinsic franchise value is probably intact, but the acquisition's return case is impaired and its recovery depends heavily on cycle timing. We would characterise the outlook as cautious/neutral: improving near-term earnings, elevated risk of further portfolio action by the parent, and limited visibility until Perstorp's FY2025–FY2026 statutory accounts or a dedicated PCG disclosure provide clearer standalone metrics.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles / notes |
|---|---|---|---|
Gorm Jensen (Aksel Gorm Jensen) | Managing Director, Perstorp Holding AB; board member | MD since 1 Feb 2025 | Previously EVP Commercial & Innovation, Perstorp (led Sayakha launch communications 2024) |
Dr. Debbie Chiu | COO, PCG Specialty Chemicals | 2025– | Articulated PCG SC four-segment ambition |
CEO, Specialty Chemicals (PCG) | Presents SC results at PCG briefings | — | Name not captured in sources accessed |
Monica Jönsson | CFO, Perstorp (appointed Mar 2023) | — | Previously deputy CFO |
Anna Berggren | VP Sustainability | — | Sustainability reporting lead |
Valentina Serra-Holm (Dr.) | VP Engineered Fluids | — | Led Amsterdam ester entry |
Lars Grimsgård | VP Corporate Finance & Investor Relations | — | IR contact |
Frida Lannerheim | VP Corporate Communication | — | — |
Håkan Kihlberg | Responsible for Project Air (per Di/Affärsvärlden, 2026) | — | — |
Board of Directors
| Name | Role | Notes |
|---|---|---|
Flavio Braunstein Kliger | Chair | PCG-appointed (background n/d) |
Gorm Jensen | Director, MD | Executive |
Mohd Azli Ishak | Director | CFO of PCG (per PCG IR 2025 financial review) |
Arasratnam Durgambikai | Director | PCG-affiliated (role n/d) |
Ralph Pieter Maria Pinckaers | Director | Background n/d |
Gerry Mikael Benjamin Ackert | Director | — |
Lars Jesper Fahlén | Director | — |
Heidi Waleniussen Englund | Director | Background n/d |
Charlotte Wolff-Bye | Director | Background n/d (formerly Petronas Group sustainability lead per secondary knowledge) |
Board & Management Changes
| Date | Change |
|---|---|
20 Jan 2023 | Jan Secher (CEO ~9+ years) steps down; Ib Jensen (CFO for one year) becomes CEO effective 1 Mar 2023; Monica Jönsson promoted to CFO |
Jan 2025 (effective 1 Feb 2025) | Ib Jensen leaves as President & CEO after overseeing PCG integration; Gorm Jensen appointed MD of Perstorp Holding AB; leadership drawn from Perstorp and BRB into PCG SC leadership team |
Major Shareholders
| Holder | Stake |
|---|---|
PETRONAS Chemicals Group Berhad | 100% (since 11 Oct 2022) |
Insider ownership | None (wholly owned) |
Competitive Landscape
Competitors by Segment
| Product area | Key competitors | Perstorp positioning |
|---|---|---|
Penta / Di-Penta | Ercros (ES), Chemanol (SA), Celanese (US), multiple Chinese producers (e.g., Hubei Yihua, Chifeng Ruiyang) | Claims global #1; multi-continent (SE, DE, US, IN) |
TMP / Di-TMP | LANXESS, Mitsubishi Gas Chemical, Chinese producers | Claims global #1; China base in Zibo |
Neo (NPG) | BASF, Eastman, Mitsubishi Gas Chemical, OQ Chemicals, LG Chem, Chinese producers | Mid-sized player |
Oxo alcohols / aldehydes | BASF, Dow, OQ Chemicals, Evonik, Sabic, Eastman, PCG's own Pengerang assets | Niche European player focused on 2-PH/valeraldehyde |
Non-phthalate plasticizers | BASF (Hexamoll DINCH), Eastman (168), Evonik (Elatur, DINP), ExxonMobil (DINP) | Differentiated via Pevalen and renewable Emoltene 100 |
Synthetic ester lubricants & dielectric fluids | Croda, Emery Oleochemicals, Zschimmer & Schwarz, M&I Materials (Midel), Cargill (FR3), Shell/ExxonMobil (immersion fluids) | Entrant (2024–25) |
Feed acidifiers / preservatives | Kemin, Trouw Nutrition (Nutreco), BASF (Lupro), Eastman, ADDCON, Novus, Anpario | Integrated acid producer + formulator |
DMPA / waterborne PU building blocks | GEO (sold business to Perstorp), Chinese producers | Leading after 2021 acquisition |
Key Competitors
| Company | FY | Revenue | Notes |
|---|---|---|---|
Perstorp (standalone) | 2021 (last disclosed) | SEK 13.5bn / EUR 1.33bn | EBITDA margin 18.6% |
PCG Specialty Chemicals (Perstorp + BRB) | 2025 | RM 5.7bn (~EUR 1.2bn) | EBITDA margin 3.9% |
BASF | 2024 | ~EUR 65bn | Diversified; competitor in oxo, Neo, plasticizers, feed |
Eastman Chemical | 2024 | ~USD 9.4bn | Oxo, Neo, TMP, plasticizers, animal nutrition |
LANXESS | 2024 | ~EUR 6.4bn | TMP, specialty additives |
Croda | 2024 | ~GBP 1.6bn | Ester lubricants, personal care |
Recent Developments
--



